Published in Catheter Cardiovasc Interv on July 01, 1999
Warming up to the reptilian heart. Catheter Cardiovasc Interv (1999) 0.75
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med (1994) 7.96
Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (1994) 4.94
Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation (1996) 3.58
Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med (1996) 3.40
Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med (1990) 3.12
The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol (2000) 2.99
Coronary artery imaging with intravascular high-frequency ultrasound. Circulation (1990) 2.97
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med (1987) 2.88
Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med (1997) 2.86
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol (2001) 2.74
Can coronary flow parameters after stent placement predict restenosis? Cathet Cardiovasc Diagn (1995) 2.69
Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation (1999) 2.67
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation (1989) 2.56
Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation (2000) 2.28
In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol (1998) 2.23
Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation (2001) 2.22
Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol (2001) 2.22
A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. N Engl J Med (1993) 2.18
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med (1987) 2.18
Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation (2001) 2.10
Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med (1997) 2.09
Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. Circulation (1997) 2.05
Impaired left ventricular diastolic filling in patients with coronary artery disease: assessment with radionuclide angiography. Circulation (1981) 2.00
A computer-based record and clinical monitoring system for ambulatory care. Am J Public Health (1977) 1.99
Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation (1996) 1.99
Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol (1995) 1.95
Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol (1995) 1.93
Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv (2001) 1.93
The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol (1998) 1.91
Seeding of intravascular stents with genetically engineered endothelial cells. Circulation (1989) 1.82
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation (1985) 1.81
Rotational coronary atherectomy after unsuccessful coronary balloon angioplasty. Am J Cardiol (1993) 1.71
Three-year clinical and angiographic follow-up after intracoronary radiation : results of a randomized clinical trial. Circulation (2000) 1.65
Femoral artery hemostasis using an implantable device (Angio-Seal) after coronary angioplasty. Cathet Cardiovasc Diagn (1996) 1.65
Incidence, management, and outcome of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol (2000) 1.64
Treatment of calcified coronary lesions with Palmaz-Schatz stents. An intravascular ultrasound study. Eur Heart J (1998) 1.62
Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol (2000) 1.60
Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. Palmaz-Schatz Stent Study Group. J Am Coll Cardiol (1994) 1.58
Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina. A clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation (1993) 1.54
Subarachnoidal hemorrhage following carotid stenting with the distal-balloon protection. Catheter Cardiovasc Interv (2001) 1.50
Prospective identification by two-dimensional echocardiography of anomalous origin of the left main coronary artery from the right sinus of Valsalva. Am J Cardiol (1991) 1.48
Vascular complications after balloon and new device angioplasty. Circulation (1993) 1.46
Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris. Am J Cardiol (1981) 1.45
Late thrombosis following intracoronary brachytherapy. Catheter Cardiovasc Interv (2000) 1.44
Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation (1995) 1.43
Catheter-based electromechanical mapping to assess regional myocardial function: a comparative analysis with transthoracic echocardiography. Catheter Cardiovasc Interv (2001) 1.43
Early and late healing responses of normal canine artery to excimer laser irradiation. J Thorac Cardiovasc Surg (1988) 1.42
Electromechanical characterization of acute experimental myocardial infarction. J Invasive Cardiol (1999) 1.42
Intravascular ultrasound findings after excimer laser coronary angioplasty. Cathet Cardiovasc Diagn (1996) 1.41
Carotid artery stenting in patients with high-risk anatomy for carotid endarterectomy. J Endovasc Ther (2001) 1.41
Integrated minimally invasive approaches for the treatment of atherosclerotic vascular diseases: Hybrid procedures. Catheter Cardiovasc Interv (2001) 1.40
Inoue balloon valvuloplasty for the tricuspid valve during pregnancy. Cathet Cardiovasc Diagn (1997) 1.40
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation (2000) 1.39
Occlusive peripheral vascular disease: a multicenter trial of fluorescence-guided, pulsed dye laser-assisted balloon angioplasty. Radiology (1991) 1.39
Long-term outcome of intracoronary microstent implantation: lesion matched comparison with Palmaz-Schatz stent. Cathet Cardiovasc Diagn (1998) 1.39
Importance of lesion length on new device angioplasty of native coronary arteries. NACI Investigators. New Approaches to Coronary Interventions. Catheter Cardiovasc Interv (2000) 1.39
Tricuspid balloon valvuloplasty: can the balloon be floated into the right ventricle? Cathet Cardiovasc Diagn (1996) 1.39
Clinical outcomes following "rescue" administration of abciximab in patients undergoing percutaneous coronary angioplasty. J Invasive Cardiol (2000) 1.38
Lesion-to-lesion relationship of the restenosis process after placement of coronary stents. Catheter Cardiovasc Interv (2000) 1.38
Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation (2000) 1.37
Chronic total obstruction and short-term outcome: the Excimer Laser Coronary Angioplasty Registry experience. Mayo Clin Proc (1993) 1.37
Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation (1997) 1.35
Treatment of spontaneous coronary artery dissection with intracoronary stenting. Am Heart J (1996) 1.34
Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation (2001) 1.31
Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med (1988) 1.31
Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation (1981) 1.30
Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation (1993) 1.26
Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation (1998) 1.26
Images in cardiovascular medicine. Cantrell's syndrome: left ventricular diverticulum in an adult patient. Circulation (2000) 1.23
Limitations of angiography in the assessment of plaque distribution in coronary artery disease: a systematic study of target lesion eccentricity in 1446 lesions. Circulation (1996) 1.23
Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries, and abnormal vasodilator reserve. Circulation (1985) 1.21
Postprocedural hypotension after carotid artery stent placement: predictors and short- and long-term clinical outcomes. Radiology (2000) 1.20
Stenting of unprotected left main coronary artery stenoses: immediate and late outcomes. J Am Coll Cardiol (1998) 1.19
Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study. J Am Coll Cardiol (1997) 1.14
Hemodynamic and clinical effects of combined verapamil and propranolol therapy in angina pectoris. Am J Cardiol (1982) 1.14
Comparison between left ventricular electromechanical mapping and radionuclide perfusion imaging for detection of myocardial viability. Circulation (1998) 1.13
Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol (2001) 1.12
Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. J Am Coll Cardiol (1995) 1.12
Delivery strategies to achieve therapeutic myocardial angiogenesis. Circulation (2000) 1.11
Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device. J Am Coll Cardiol (1995) 1.11
Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions : intravascular ultrasound study of 2256 patients. Circulation (2000) 1.10
Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents. J Am Coll Cardiol (1998) 1.10
Management of restenosis within the Palmaz-Schatz coronary stent (the U.S. multicenter experience. The U.S. Palmaz-Schatz Stent Investigators. Am J Cardiol (1993) 1.09
Intravascular ultrasound evaluation of the effect of rotational atherectomy in obstructive atherosclerotic coronary artery disease. Circulation (1992) 1.09
Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. J Am Coll Cardiol (2000) 1.06
The effect of i.v. sumatriptan, a selective 5-HT1-receptor agonist on central haemodynamics and the coronary circulation. Br J Clin Pharmacol (1992) 1.06
Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients. Am J Cardiol (1998) 1.05
Long-term follow-up after percutaneous transluminal coronary angioplasty was not performed based on intravascular ultrasound findings: importance of lumen dimensions. Circulation (1999) 1.04
Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revascularization. J Am Coll Cardiol (1996) 1.04
High speed rotational atherectomy: outcome in calcified and noncalcified coronary artery lesions. J Am Coll Cardiol (1995) 1.03
Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis. Am J Cardiol (1996) 1.03
Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. Am J Cardiol (2000) 1.02
Conduction blocks following transcatheter septal ablation for hypertrophic cardiomyopathy. Eur Heart J (1997) 1.02
Tissue proliferation within and surrounding Palmaz-Schatz stents is dependent on the aggressiveness of stent implantation technique. Am J Cardiol (1999) 1.02